John Patava
Direttore operativo presso AUM Biosciences Pte Ltd.
Provenienza dei contatti di primo grado di John Patava
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
AUM Biosciences Ltd.
AUM Biosciences Ltd. BiotechnologyHealth Technology Aum Biosciences Ltd. is a global clinical-stage oncology. It is focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance. The company was founded on October 28, 2022 and is headquartered in George Town, Cayman Islands.
5
| Holding Company | Biotechnology | 5 |
AUM Biosciences Pte Ltd.
AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John Patava tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Auckland University | College/University | Doctorate Degree | |
University of Canterbury | College/University | Graduate Degree | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Actis LLP
Actis LLP Investment ManagersFinance Actis LLP (Actis) is a private equity firm founded in 1948 by Sreenivasulu Vudayagiri and Pavel Alexandrovich Cherkashin. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Everlife Holdings Pte. Ltd.
Everlife Holdings Pte. Ltd. Medical DistributorsDistribution Services Everlife Holdings Pte. Ltd. operates as analytical, medical and laboratory devices distribution platform. It provides distribution solution that includes sales, marketing, registration, biomedical engineering services, technical and clinical support to south east Asian markets. The company was founded in 2017 and is headquartered in Singapore. | Medical Distributors | Chairman | |
Everstone Capital Asia Pte Ltd.
Everstone Capital Asia Pte Ltd. Investment ManagersFinance Everstone Capital Asia Pte Ltd (Everstone Capital Asia) is a private equity firm, a subsidiary of Everstone Capital Ltd founded in 2006 by Sameer Sushil Sain and Atul Kapur. The firm is headquartered in Singapore with additional office offices in Mumbai, New Delhi, Gurgaon, New York, Dubai and Mauritius. | Investment Managers | Private Equity Investor | |
OmniActive Health Technologies Ltd.
OmniActive Health Technologies Ltd. Pharmaceuticals: OtherHealth Technology OmniActive Health Technologies Ltd. manufactures and sell natural ingredients. It offers carotenoids, plant extracts, and specialty functional ingredients. The company was founded in 2004 and is headquartered in Mumbai, India. | Pharmaceuticals: Other | Director/Board Member | |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Pharmaceuticals: Generic | Director/Board Member | |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Nuova-Zelanda | 3 |
Regno Unito | 3 |
Singapore | 3 |
India | 2 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Finance | 3 |
Commercial Services | 2 |
Distribution Services | 2 |
Posizioni
Director/Board Member | 10 |
Independent Dir/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Contatti più connessi
Insiders | |
---|---|
Ross Horsburgh | 6 |
Arjun Oberoi | 6 |
Madhav Devalaraja | 3 |
Vishal Doshi | 2 |
Harish Dave | 2 |
- Borsa valori
- Insiders
- John Patava
- Connessioni Società